Stock Market Stories and Insights

Northern Technologies is currently does not generate positive expected returns and assumes 2.6537% risk (volatility on return distribution) over the 90 days horizon. While some risk-loving traders are indifferent towards current market volatility, it is reasonable to go over the risk of investing in Northern Technologies Intl. We will evaluate if Northern Technologies' current volatility will continue into August.
  over two months ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik
Today we may see the proof that Kimberly-Clark Corp would recover much slower from the current slip as its shares went up 0.65% to Helen Of's 0.7114%. As many rational traders are trying to avoid consumer defensive space, it makes sense to digest Helen Of Troy a little further and understand how it stands against Kimberly-Clark Corp and other similar entities. We are going to discuss some of the competitive aspects of both Helen and Kimberly-Clark.
  over two months ago at Macroaxis 
By Raphi Shpitalnik
Raphi Shpitalnik
Park Electrochemical Corp is scheduled to announce its earnings tomorrow. Park Electrochemical Average Equity is projected to increase significantly based on the last few years of reporting. The past year's Average Equity was at 284.44 Million. The current year Invested Capital is expected to grow to about 170.7 M, whereas Enterprise Value is forecasted to decline to about 358.7 M. Although many aggressive traders are getting into industrials space, Park Electrochemical Corp may or may not be your first choice. We will check if the company can maintain a respectable level of debt while minimizing operating losses.
  over two months ago at Macroaxis 
By Gabriel Shpitalnik
Gabriel Shpitalnik
While this unique economic environment continues, Simulations Plus may throw investors more surprises in few weeks. Why are we still confident in our hopes for a recovery. On the 5th of July the company is traded for 49.86. Simulations Plus has historical hype elasticity of 0.02. The average price elasticity to hype of competition is about 0.01. The entity is expected to increase in value after the next press release, with the price going to jump to 49.88. The recent volatility of headline impact on Simulations Plus stock price is is way over 100 percent making price predictions on social media along less reliable. The price boost on the next news is forecasted to be 0.04%, whereas the daily expected return is at this time at 0.13%. Considering the 90-day investment horizon the next expected announcement will be in about 8 days.
  over two months ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik
Today's article will recap Simulations Plus. We will evaluate if Simulations Plus shares are reasonably priced going into August. On the 5th of July the company is traded for 51.00. Simulations Plus has historical hype elasticity of -0.38. The average price elasticity to hype of competition is about -0.24. The entity is expected to decline in value after the next headline, with the price expected to drop to 49.48. The average volatility of media hype impact on Simulations Plus stock price is way over 100%. The price depreciation on the next news is expected to be -0.76%, whereas the daily expected return is at this time at 0.13 percent. The volatility of related hype on Simulations Plus is about 176.6% with expected price after next announcement by competition of 50.76 Considering the 90-day investment horizon the next expected press release will be in about 7 days.
  over two months ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
My story will break down Biotricity. I will address few reasons this entity was abused by investors due to the current market volatility. Biotricity is currently traded for 1.60. The entity has historical hype elasticity of 0.01. The average price elasticity to hype of competition is about -0.92. The firm is forecasted to increase in value after the next headline, with the price going to jump to 1.76. The current volatility of media hype impact on the company stock price is is way over 100 percent making price predictions on social media along less reliable. The price jump on the next news is forecasted to be 0.57%, whereas the daily expected return is currently at -0.13%. The volatility of related hype on Biotricity is about 108.59% with expected price after next announcement by competition of 0.68 Given the investment horizon of 90 days the next forecasted press release will be in about 3 days.
  over two months ago at Macroaxis 
By Gabriel Shpitalnik
Gabriel Shpitalnik
Oxford Biomedical is scheduled to announce its earnings tomorrow. As many investors are getting excited about healthcare space, it is fair to digest Oxford Biomedical as an investment option. Here we also measure the ability of Oxford Biomedical to meet its long-term debt obligations, such as interest payments on debt, the final principal payment on the debt, and any other fixed obligations like lease payments.
  over two months ago at Macroaxis 
By Raphi Shpitalnik
Raphi Shpitalnik
Global Cord Blood is scheduled to announce its earnings tomorrow. Global Cord Earnings per Basic Share are quite stable at the moment as compared to the past year. The company's current value of Earnings per Basic Share is estimated at 5.19. Earnings per Diluted Share is expected to rise to 5.19 this year, although the value of Average Assets will most likely fall to about 7.4 B. As many millenniums are trying to avoid healthcare space, it makes sense to outline Global Cord Blood a little further and try to understand its current market patterns. We will analyze why Global Cord investors may still consider a stake in the business.
  over two months ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik